REGENXBIO Price Target Cut to $36.00/Share From $40.00 by HC Wainwright & Co.

Dow JonesNov 21 07:01 ET · Ratings

H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Cuts Target Price to $36

Moomoo NewsNov 21 06:31 ET · Ratings

Buy Rating on RegenXBio Driven by Positive RGX-202 Trial Results and Strong Approval Prospects

TipRanksNov 21 06:16 ET · Ratings

Express News | Regenxbio Inc. : H.c. Wainwright Cuts Target Price to $36 From $40

ReutersNov 21 06:05 ET

Barclays Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsNov 21 05:34 ET · Ratings

REGENXBIO Price Target Maintained With a $52.00/Share by Chardan Capital

Dow JonesNov 20 06:11 ET · Ratings